Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.

Katori M, Majima M.

Inflamm Res. 2000 Aug;49(8):367-92. Review.

PMID:
11028754
2.

The advent of highly selective inhibitors of cyclooxygenase--a review.

Cryer B, Dubois A.

Prostaglandins Other Lipid Mediat. 1998 Aug;56(5-6):341-61. Review.

PMID:
9990677
3.

The role of cyclooxygenases in inflammation, cancer, and development.

Williams CS, Mann M, DuBois RN.

Oncogene. 1999 Dec 20;18(55):7908-16. Review.

4.

COX-2 in brain and spinal cord implications for therapeutic use.

Hoffmann C.

Curr Med Chem. 2000 Nov;7(11):1113-20. Review.

PMID:
11032961
5.

COX selectivity and animal models for colon cancer.

Oshima M, Taketo MM.

Curr Pharm Des. 2002;8(12):1021-34. Review.

PMID:
11945149
6.

Cyclooxygenase 2: from inflammation to carcinogenesis.

Ristimäki A.

Novartis Found Symp. 2004;256:215-21; discussion 221-6, 259-69. Review.

PMID:
15027493
7.

Role of cyclooxygenase-1 and -2 in health and disease.

Lipsky PE.

Am J Orthop (Belle Mead NJ). 1999 Mar;28(3 Suppl):8-12. Review.

PMID:
10193997
8.
9.

The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition.

Singh-Ranger G, Mokbel K.

Eur J Surg Oncol. 2002 Nov;28(7):729-37. Review.

PMID:
12431470
10.

COX-1 and COX-2 in health and disease.

Adelizzi RA.

J Am Osteopath Assoc. 1999 Nov;99(11 Suppl):S7-12. Review.

PMID:
10643175
11.

[Multiple roles of inducible cyclooxygenase-2 and its selective inhibitors].

Katori M, Majima M.

Nihon Yakurigaku Zasshi. 1997 Jun;109(6):247-58. Review. Japanese.

PMID:
9253772
12.

The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.

Buttar NS, Wang KK.

Mayo Clin Proc. 2000 Oct;75(10):1027-38. Review.

PMID:
11040851
13.
14.

Cyclooxygenase knockout mice: models for elucidating isoform-specific functions.

Langenbach R, Loftin C, Lee C, Tiano H.

Biochem Pharmacol. 1999 Oct 15;58(8):1237-46.

PMID:
10487525
15.

Characterization of prostaglandin H synthase 2 deficient mice and implications for mechanisms of NSAID action.

Morham SG, Langenbach R, Mahler J, Smithies O.

Adv Exp Med Biol. 1997;407:131-8. No abstract available.

PMID:
9321943
16.

Cyclooxygenase-2: a therapeutic target.

Turini ME, DuBois RN.

Annu Rev Med. 2002;53:35-57. Review.

PMID:
11818462
17.

COX-2 and colon cancer.

Taketo MM.

Inflamm Res. 1998 Oct;47 Suppl 2:S112-6.

PMID:
9831333
18.

Cyclo-oxygenase isoenzymes: physiological and pharmacological role.

Kam PC, See AU.

Anaesthesia. 2000 May;55(5):442-9. Review.

19.

Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.

Reese J, Zhao X, Ma WG, Brown N, Maziasz TJ, Dey SK.

Endocrinology. 2001 Jul;142(7):3198-206.

PMID:
11416042
20.

Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?

Lipsky PE.

J Rheumatol Suppl. 1999 Apr;56:25-30. Review.

PMID:
10225537

Supplemental Content

Support Center